Thursday, February 12, 2009

Learn How to Protect Your Heart


Nautilus Health and Nutrition News
February 12, 2009
By: Graciela Ayllon and Marco Ayllon

Saturday is Valentine's Day, and February is American Heart Month. I don't know about you, but I'm definitely picking up a signal here — kind of a thump, thump, thump — that it's important to pay attention to heart health.


Great strides have been made in the detection and treatment of heart disease, still the nation's No. 1 killer, although the numbers are improving.

Seeing red
The Go Red for Women campaign (GoRedForWomen.org), sponsored by

the American Heart Association,

kicked off Feb. 1 with Wear Red days, luncheons and talks across the country. The event continues through April 1. Why should you go red?


Heart disease is the No. 1 killer of women.One in three women has some form of heart disease.Women account for more than 52 percent of cardiovascular disease deaths.Since 1984, cardiovascular disease deaths for women have outstripped those for men.One in three women doesn't yet know that heart disease is her greatest health risk.
So what should you be doing to help your heart stay healthy? Here are some tips from organizations that have taken your heart health to heart.


TAKE CARE OF THE BASICS
™¥ Stop smoking or using tobacco products and avoid secondhand smoke. Stop smoking and your risk for smoking-related heart problems drops sharply after just one year.

™¥ Get active in any way you like. Participation in regular exercise can reduce your risk of fatal heart disease by nearly 25 percent.

™¥ Eat a heart-healthy diet. That doesn't mean eliminating foods you love, but cutting back and filling in the spaces with fruits, vegetables, whole grains and low-fat dairy products will tell your heart you're thinking of it with every bite.

™¥ Get to a healthy weight and stay there. Excess weight can contribute to high blood pressure, high cholesterol and diabetes. Learn your body mass index (BMI) and target a healthy number with diet and exercise.

™¥ Get regular screenings. Keep track of cholesterol and blood pressure and take action when numbers pose a problem.

Learn more at the American Heart Association Web site, www.americanheart.org.


KNOW THE SYMPTOMS OF A HEART ATTACK
™¥ Uncomfortable pressure, fullness or a squeezing sensation in the center of your chest. It may last a few minutes, or go away and come back.

™¥ Chest discomfort that spreads to your shoulders, neck, jaw, arms or back.

™¥ Chest discomfort that arrives with lightheadedness, fainting, sweating, nausea or shortness of breath.

™¥ Don't wait if you or someone else exhibits these symptoms. Call 911 right away.

™¥ If you think you might be having a heart attack, chew or crush and swallow a regular aspirin tablet.

Visit the Web site of the American College of Emergency Physicians at www.acep.org.


BE A PROACTIVE PARTNER
™¥ Take a cardiopulmonary resuscitation (CPR) class. The American Heart Association offers a CPR Anytime kit that lets you learn the skill at home.

™¥ Purchase an automated external defibrillator (AED) for your home, school or office and learn how to use it.

™¥ Encourage your valentine to adopt heart-healthy activities by joining in yourself. Make a date to work out together; even a daily after-dinner walk will do wonders.

™¥ Give a heart-healthy gift of dark chocolate or red wine. Both contain high levels of antioxidants, which help increase HDL, or so-called "good" cholesterol.

Learn more at www.americanheart.org and www.suddencardiacarrest.org.

Two women suffer organ failure after cosmetic bottom injections to make them look like J.Lo


Perfection: Andrea Lee and her friend Zakiya Teagle thought they could achieve a bottom like Jennifer Lopez's

Nautilus Health and Nutrition News
February 12, 2009
By: Graciela Ayllon and Marco Ayllon

Two women are fighting for their lives after cosmetic injections aimed at giving them 'J.Lo' style bottoms went disastrously wrong.

Andrea Lee, 30, suffered total kidney failure after being 'poisoned' with what is believed to be industrial silicone.
Her friend Zakiya Teagle, 33, is also in a critical condition in a Florida hospital after her internal organs stopped functioning.
Police in Tampa, Florida, are now searching for the fake doctor who carried out the cosmetic procedures on both women.
Sharhonda Lindsay, 32, has gone on the run after the two women were rushed to hospital with critical injuries caused by her injections.
According to police, Lindsay, who has no medical licence or cosmetic surgery experience, performed the 'butt shots' at her home last month.
Ms Lee and Ms Teagle paid more than £300 to have a series of silicone injections that they hoped would enhance the shape and size of their bottoms.
Friends said the women hoped to copy the fuller-figure look that singer Jennifer Lopez is famous for.
Investigators said Lindsay used a plastic bottle and a Tupperware bowl to mix the solution.
One woman received 40 shots within a 90-minute period. The other had 20 in the same amount of time.
Detectives say the two victims were told they were being injected with a silicone substance called 'Hydrogel'.
But they think a stronger industrial silicone was used.
Ms Lee's mother Dorethea Belnavis said her daughter started getting extremely ill within several hours of having the injections.
She said her daughter was in a critical condition in a Tampa hospital after damage to her kidneys, liver and lungs.
'She's fighting for her life right now,' said Ms Belnavis.
Police have appealed to other women in the Tampa area to come forward if they have had any dealings with Lindsay.

Balanced Diet Could Cut Risk of Dementia


Nautilus Health and Nutrition News
February 12, 2009
By: Graciela Ayllon

A new study suggests a diet laden with fish, olive oil, veggies and other foods common in Mediterranean-style cuisine may help ward off mild cognitive impairment, sometimes called borderline dementia. The study also suggests this diet reduces the chance of transitioning from mild cognitive decline to Alzheimer's disease.


"We know from previous research that a healthy diet like this is protective for cardiovascular risk factors like cholesterol, hypertension and diabetes. Now this current study shows it may help brain function too," says Nikolaos Scarmeas, assistant professor of clinical neurology at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center.

ALZHEIMER'S RESOURCE PAGE: What you need to know
EARLY ALZHEIMER'S: Disease can erode driving skills

Scarmeas and other researchers at Columbia examined, interviewed and screened 1,393 individuals with healthy brains and 482 patients with mild cognitive impairment. Study participants were questioned about their eating habits.

The study, in this month's Archives of Neurology, reports that over an average of 4½ years of follow-up, 275 of the 1,393 study participants who did not have mild cognitive impairment developed the condition. Those who had the highest adherence to a Mediterranean diet — a menu rich in vegetables, legumes and fish, low in fat, meat and dairy, and high in monounsaturated fats like those in olive oil — had a 28% lower risk of developing mild cognitive impairment than the one-third of participants who had the lowest scores for Mediterranean diet adherence. The middle one-third group had a 17% lower risk of developing mild cognitive impairment than those who ate the fewest Mediterranean foods.

BETTER LIFE: Studies on Alzheimer's and dementia
BOB BLACKWELL'S BLOG: Skiing with early Alzheimer's

Of the 482 study participants who had mild cognitive impairment at the beginning of the study, 106 developed Alzheimer's disease roughly 4 years later. The one-third of participants with the highest scores for Mediterranean diet adherence had a 48% less risk of developing Alzheimer's than the one-third with the lowest diet scores.

Previous research has found a similar association for subjects with Alzheimer's disease, but this is the first report connecting a Mediterranean diet with decreased risk of mild cognitive impairment, says Scott Turner, program director of the Memory Disorders Program at Georgetown University. "The findings are important and intriguing."

Scarmeas says clinical studies that randomly assign people to a Mediterranean diet or another diet are needed to prove that a Mediterranean diet protects against cognitive decline.

But beginning healthier eating habits earlier than the golden years may be the key, says Duke University Medical Center aging expert Murali Doraiswamy. "Since Alzheimer's changes may start in the brain decades before memory loss occurs, what you eat starting in your midlife may be crucial," he says.

Share this story:

Study Says Multivitamins Not Effective


Nautilus Health and Nutrition News
February 12, 2009
By: Graciela Ayllon

Americans spend more than 20 billion dollars each year on vitamin supplements, but new research suggests they might not be lowering their risk for disease.

Experts at Fred Hutchinson Cancer Research Center studied data from over 160,000 women who were followed for at least eight years.

Of those women, just over 40% reported daily vitamin use.

They found no difference in cancer rates between women who took supplements and those who didn’t.

Supplement users also had the same rates of heart disease and death.

Experts say getting nutrients from food may be the best way a woman can lower her risk for disease.

A representative from The Council For Responsible Nutrition, a supplement industry group, says multivitamins are meant to be used as part of a healthy lifestyle, not as magic bullets that assure the prevention of chronic diseases.

Looking for a Sign of Deadly Prostate Cancer


Nautilus Health and Nutrition News
February 12, 2009
By: Marco A. Ayllon

A simple test for high levels of the chemical sarcosine could help in prognosis, according to a study in the journal Nature. The finding could lead to new ways of preventing the spread of tumors.

It may soon be possible to distinguish aggressive prostate tumors requiring immediate treatment from those that grow slowly and can be safely ignored, a problem that has vexed oncologists and patients for decades.


Looking at the complete profiles of chemicals produced by prostate tumors, researchers found that levels of sarcosine -- a simple derivative of the amino acid glycine -- are substantially higher in patients with aggressive tumors, they reported Wednesday in the journal Nature.

Levels of sarcosine in the blood could be easily and cheaply identified with a simple test that could replace or complement the prostate-specific antigen, or PSA, test now widely used in prostate cancer patients. The PSA is very useful for identifying the presence of tumors, but says little about their ultimate prognosis.

Perhaps equally important as the metabolic findings, tests in laboratory dishes showed that adding sarcosine to benign tumors dramatically increased their aggressiveness, while blocking sarcosine production in aggressive tumors rendered them much less potent.

The findings may eventually lead to new ways of preventing the spread of the tumors, said Dr. Arul M. Chinnaiyan, a pathologist at the University of Michigan Medical School and senior author of the Nature paper.


Prostate cancer is the most common form of cancer in American men, with an estimated 186,320 cases diagnosed last year, according to the American Cancer Society. About 28,660 men died of the disease in 2008. And 80% of men over the age of 80 develop it.

The conundrum for clinicians is that while many of the tumors can be highly aggressive and immediately life-threatening, others are so slow-growing that they can be safely ignored, a concept known as watchful waiting. But there has not been any good way to distinguish between the two forms.

If physicians could distinguish between the forms, they could minimize unnecessary treatment of patients who are likely to die of other causes before their prostate tumors progress, Chinnaiyan said. That treatment is expensive and can lead to side effects such as impotence and incontinence.

To address the problem, the Michigan group used the new science of metabolomics, in which researchers look at all the metabolites -- chemicals produced during metabolism -- associated with an organ. They studied 1,126 metabolites in 262 samples of healthy prostate tissue, localized prostate tumors and aggressive or metastatic prostate cancer.

The researchers identified 10 chemicals whose levels increased during prostate cancer progression. The most dramatic results were with sarcosine: Levels were elevated sharply in 79% of metastatic cancer patients and less sharply in 42% of early stage patients. The chemical was not found at all in cancer-free samples.

The chemical was also readily detected in the urine of prostate cancer patients, suggesting that it may be possible to develop a simple, noninvasive test for the tumor. Their overall findings have to be validated in larger studies, Chinnaiyan said, but a urine test could be available in three to five years.

To the researchers' surprise, they also found that manipulating sarcosine levels in the test tube could alter the course of tumor growth, suggesting that the chemical plays an as-yet-unknown role in metastasis. If that proves to be the case, chemicals that block its production could serve as new cancer drugs.

The team is now taking a closer look at the other chemicals whose concentrations change with tumor progression. Using a panel of chemicals rather than just one would provide a more accurate diagnosis, Chinnaiyan said.

Analyzing metabolites is "particularly attractive" because it could provide an accurate assessment of tumors' cellular physiology and biochemical activity, wrote Dr. Cory Abate-Shen and Dr. Michael M. Shen in an editorial accompanying the paper. The Michigan team's is the first application of metabolomics to tumors, and the researchers speculate that further studies could produce diagnostic markers for a broad variety of cancers.